TabsDetailsBasic DetailsDate Posted: Wednesday, January 9, 2013Status: CompleteMedical Product: bupropion, naltrexoneDescription: Modular program-based one-time assessment of the use of bupropion and naltrexonein the Mini-Sentinel Distributed Database. Modular programs are adaptable standardized programs. Queries were executed in October-November 2011.If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer. Read More Deliverables (1)Mini-Sentinel Modular Program Report: Buproprion Naltrexone Use 1Additional InformationAdditional DetailsFDA Center: CDERStudy Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: 2005-2010Data Sources: Mini-Sentinel Distributed Database (MSDD)
